We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$127M
Cap. Flow
+$25.8M
Cap. Flow %
2.3%
Top 10 Hldgs %
73.92%
Holding
31
New
3
Increased
10
Reduced
17
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 22.71%
2 Communication Services 21.64%
3 Healthcare 12.51%
4 Consumer Discretionary 10.07%
5 Consumer Staples 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
26
DELISTED
Activision Blizzard
ATVI
-69,715
Closed -$6.53M

Similar funds

Bronte Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bronte Capital Management held 31 positions worth $1.12B, up 13% from $993M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Bronte Capital Management's Q4 2023 filing shows 3 new, 10 increased, 17 reduced and 1 closed positions. Its largest new stake was Vertex Pharmaceuticals: 20,760 shares worth $8.45M. The largest sale was Activision Blizzard, an estimated $6.53M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

  • Bronte Capital Management's largest Q4 2023 buy was Vertex Pharmaceuticals: 20,760 shares worth $8.45M.
  • Bronte Capital Management added most to Amazon in Q4 2023, an estimated $16.4M increase.
  • Bronte Capital Management's biggest Q4 2023 reduction was General Mills, cutting an estimated $2.56M.
  • Bronte Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $6.53M.
  • Bronte Capital Management's ten largest holdings make up 74% of its $1.12B portfolio in Q4 2023.
  • Bronte Capital Management opened 3 new positions and closed 1 in Q4 2023.
  • Bronte Capital Management's portfolio value rose 13% quarter-over-quarter to $1.12B.

Based on Bronte Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.